|
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2008, vol. 14, book 1
Subject Collection: Medicine
Page: 72-75
DOI: 10.5272/jimab.14-1-2010.72
Online date: October 07, 2008
J of IMAB 2008; 14(1)72-75
SNEDDON’S SYNDROME
Valentin Valtchev1 , Virginia Simeonova2, Dimitar Gospodinov1 , Ivelina Yordanova1 , Valentina Dimitrova1, Verka Pavlova1, Emiliana Konova4, Savelina Popovska3, Boyko Stamenov2
1) Department of Dermatology and Venereology, Medical University – Pleven, Bulgaria
2) Department of Neurology, Medical University – Pleven, Bulgaria
3) Department of General and Clinical Pathology, Medical University – Pleven, Bulgaria
4) Department of Immunology, Medical University – Pleven, Bulgaria
ABSTRACT:
Sneddon’s syndrome is usually characterized by the association of an ischemic cerebrovascular disease and a widespread livedo reticularis. The incidence of Sneddon syndrome is 4/1000 000. We present 42-year-old woman with livedo reticularis, recurrence ischaemic cerebrovascular accidents, two repetitive miscarriages and positive anti-2GPi antibodies. Skin biopsy specimens reveal inflammatory changes of small- to medium-sized arteries and subendothelial proliferation and fibrosis. The diagnosis Sneddon syndrome is confirmed by skin biopsy, and MR evidence.
We suggest that anti-2GPi antibodies may be pathophysiologically related to the clinical manifestation observed in some patients with Sneddon syndrome.
Key words: Sneddon syndrome, livedo reticularis, ischemic cerebrovascular disease.
- Download FULL TEXT (PDF - 372 KB)
Please cite this article as:
Valtchev V, Simeonova V, Gospodinov D, Yordanova I, Dimitrova V, Pavlova V, Konova E, Popovska S, Stamenov B. SNEDDON’S SYNDROME. J of IMAB. 2008; 14(1):72-75. DOI: 10.5272/jimab.14-1-2010.72
REFERENCES:
1. Baleva M, Chauchev A, Dikova C et al. Sneddon syndrome: echocardiographic, neurological and immunological findings. Stroke 1995;26(7):1303-4.
2. Blom RJ. Sneddon syndrome: CT, arteriography and MR imaging. J Comput Assist Tomogr 1989;13(1):119-22.
3. Fine RM. Sneddon syndrome: a diagnosis you do not want to miss. Int J Dermatol 1990;29(7):479-80.
4. Gancheva M., Tsankov N. Livedo reticularis and cerebrovascular accident (Sneddon’s Syndrome) as a clinical expression of antiphospholipid syndrome. J EUR Acad Dermatol Venereol 1999; 12(2): 157-160.
5. Geschwind DH, FitzPatrick M, Mischel PS, Cummings JL. Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology 1995;45(3 Pt 1):557-60.
6. Levine SR, Langer SL, Alberts JW, Welch KMA. Sneddon's syndrome: an antiphospholipid antibody syndrome? Neurology 1988;38(5):798-800.
7. Marsch WC, Muckelmann R. Generalized racemosa livedo with cerebrovascular lesions (Sneddon syndrome): an occlusive arteriolopathy due to proliferation and migration of medial smooth muscle cells. Br J Dermatol 1995;112(6):703-8.
8. Richard MA, Grob JJ, Durand JM, Noe C, Basseres N, Bonerandi JJ. Le syndrome de Sneddon. Ann Dermatol Venereol 1994;121(4):331-7.
9. Sempere AP, Martinez B, Bermejo F, Tahoces MF, Cabello A. Sneddon's syndrome: its clinical characteristics and etiopathogenic factors. Rev Clin Esp 1992;191(1):3-7.
10. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965;77:180-5.
11. Zelger B, Sepp N, Schmid KW, Hintner H, Klein G, Fritsch PO. Life history of cutaneous vascular lesions in Sneddon's syndrome. Hum Pathol 1992;23(6):668-75.
12. Zelger B, Sepp N, Stockhammer G et al. Sneddon's syndrome. A long term follow-up of 21 patients. Arch Dermatol. 1993;129(4):437-47.
back to Online Journal |